India to Sudan: Cefuroxime Export Trade Route

The India to Sudan Cefuroxime corridor is one of India's established pharmaceutical export routes, with 150 shipments documented worth a combined $4.3M USD. The route is dominated by SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI, which alone accounts for roughly 39% of all export value, reflecting the consolidated nature of India's cefuroxime manufacturing sector.

Across 23 active suppliers, the average shipment value stands at $28.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with cefuroxime's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 13.5%, placing it at rank #1 among India's top cefuroxime export destinations globally.

On the import side, key buyers of Indian cefuroxime in Sudan include TO THE DIRECTOR OF, TO THE ORDER OF, TO THE ORDER and 30 others. TO THE DIRECTOR OF is the single largest importer with 25 shipments valued at $621.0K USD.

India's cefuroxime exports to Sudan are driven primarily by a handful of large-scale manufacturers. SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI with 62 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 23 active exporters signals a competitive but concentrated market — buyers in Sudan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI, KILITCH DRUGS INDIA LIMITED, SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI — together account for 61% of total trade value on this route. The average shipment value of $28.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmceutical products- zinax 0.75 gm cefuroxime sodium powder for injection usp 0.75gm + 10ml swfi and harmless pharmaceutical medicines finished formulation cefuroxime for inj usp 750mg futum 750mg inj (plst wfi) b.no.0234vls, suggesting that buyers in Sudan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE DIRECTOR OF is the largest importer with 25 shipments worth $621.0K USD — representing 15% of all cefuroxime imports from India on this route. A total of 33 buyers are active on this corridor.